PL2142186T3 - Stosowanie oligomerów kwasu mlekowego w leczeniu zaburzeń ginekologicznych - Google Patents
Stosowanie oligomerów kwasu mlekowego w leczeniu zaburzeń ginekologicznychInfo
- Publication number
- PL2142186T3 PL2142186T3 PL08734874T PL08734874T PL2142186T3 PL 2142186 T3 PL2142186 T3 PL 2142186T3 PL 08734874 T PL08734874 T PL 08734874T PL 08734874 T PL08734874 T PL 08734874T PL 2142186 T3 PL2142186 T3 PL 2142186T3
- Authority
- PL
- Poland
- Prior art keywords
- oligomers
- treatment
- lactic acid
- gynaecological infections
- gynaecological
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200700508 | 2007-03-30 | ||
EP08734874.4A EP2142186B1 (en) | 2007-03-30 | 2008-03-28 | Use of oligomers of lactic acid in the treatment of gynaecological infections |
PCT/EP2008/002505 WO2008119518A1 (en) | 2007-03-30 | 2008-03-28 | Use of oligomers of lactic acid in the treatment of gynaecological disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2142186T3 true PL2142186T3 (pl) | 2014-09-30 |
Family
ID=39494560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08734874T PL2142186T3 (pl) | 2007-03-30 | 2008-03-28 | Stosowanie oligomerów kwasu mlekowego w leczeniu zaburzeń ginekologicznych |
Country Status (19)
Country | Link |
---|---|
US (3) | US8425894B2 (pl) |
EP (2) | EP2679222A1 (pl) |
JP (2) | JP5409596B2 (pl) |
KR (1) | KR101518014B1 (pl) |
CN (2) | CN103830216B (pl) |
AU (1) | AU2008234064B2 (pl) |
BR (1) | BRPI0809330B8 (pl) |
CA (1) | CA2681803C (pl) |
CY (1) | CY1115310T1 (pl) |
DK (1) | DK2142186T3 (pl) |
ES (1) | ES2482190T3 (pl) |
HR (1) | HRP20140559T1 (pl) |
MX (1) | MX2009010445A (pl) |
PL (1) | PL2142186T3 (pl) |
PT (1) | PT2142186E (pl) |
RU (1) | RU2459620C2 (pl) |
SI (1) | SI2142186T1 (pl) |
WO (1) | WO2008119518A1 (pl) |
ZA (1) | ZA200907215B (pl) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008119518A1 (en) | 2007-03-30 | 2008-10-09 | Laccure Ab | Use of oligomers of lactic acid in the treatment of gynaecological disorders |
CN101797269B (zh) * | 2010-03-23 | 2012-01-04 | 杨霞 | 一种调节女性***微生态的生理平衡液 |
WO2012158779A1 (en) | 2011-05-17 | 2012-11-22 | Reprotect, Inc. | Reusable intravaginal delivery device, system, and method |
CN102274333A (zh) * | 2011-08-22 | 2011-12-14 | 谢英华 | 一种治疗***炎的外洗中药 |
CN102579829B (zh) * | 2012-03-06 | 2013-09-18 | 康莉 | 一种治疗牛放线菌病的中药组合物及其制备方法 |
AP2014008149A0 (en) | 2012-06-13 | 2014-12-31 | Evofem Inc | Compositions and methods for enhancing the efficacy of contraceptive microbicides |
CA2875784C (en) * | 2012-07-16 | 2020-03-10 | Laccure Ab | Pharmaceutical compositions containing oligomeric lactic acid |
CN102885850B (zh) * | 2012-10-15 | 2013-08-07 | 山东省医疗器械研究所 | 一种治疗***炎的多孔凝胶颗粒剂 |
BR112016014506B1 (pt) | 2013-12-19 | 2022-06-28 | Evofem, Inc | Composição para contraceptivo de tamponamento ácido à base de ácido algínico |
US9895311B2 (en) * | 2014-09-25 | 2018-02-20 | Pharmiva Ab | Foam-forming compositions and methods for delivering an active to a body cavity |
ES2896680T3 (es) | 2016-04-06 | 2022-02-25 | Gedea Biotech Ab | Glucono delta lactona para el tratamiento de infecciones fúngicas vaginales |
US10249017B2 (en) * | 2016-08-11 | 2019-04-02 | Intel Corporation | Apparatus and method for shared resource partitioning through credit management |
WO2018049326A1 (en) * | 2016-09-12 | 2018-03-15 | Evofem Biosciences, Inc. | Combination gel for sexually transmitted infections |
AU2017338748A1 (en) | 2016-10-04 | 2019-05-02 | Evofem Inc. | Method of treatment and prevention of bacterial vaginosis |
MX2019004238A (es) * | 2016-10-13 | 2019-11-08 | Catalent Uk Swindon Zydis Ltd | Composiciones farmaceuticas liofilizadas para suministro vaginal. |
ES2968763T3 (es) * | 2018-03-29 | 2024-05-13 | The Materia Company Ltd | Formulación intravaginal |
WO2023165971A1 (en) | 2022-03-01 | 2023-09-07 | Laccure Ab | Process for preparation of compositions of oligomers of lactic acid |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4431427A (en) * | 1981-10-05 | 1984-02-14 | University Of Delaware | Tampons and their manufacture |
US5274127A (en) * | 1990-09-18 | 1993-12-28 | Biopak Technology, Ltd. | Lactide production from dehydration of aqueous lactic acid feed |
JP2919912B2 (ja) | 1990-05-23 | 1999-07-19 | 鐘紡株式会社 | 修飾プロテアーゼ及びその製造法 |
US5142023A (en) * | 1992-01-24 | 1992-08-25 | Cargill, Incorporated | Continuous process for manufacture of lactide polymers with controlled optical purity |
JPH07132127A (ja) | 1993-06-17 | 1995-05-23 | Mitsui Toatsu Chem Inc | 生理用ナプキン |
DE19506395A1 (de) | 1994-02-24 | 1995-08-31 | Ecological Chem Prod | Zusammensetzung und Verfahren zum Verpacken feuchtigkeitshaltiger Lebensmittel |
US5521278A (en) * | 1994-08-18 | 1996-05-28 | Ecological Chemical Products | Integrated process for the manufacture of lactide |
JP2864218B2 (ja) | 1994-12-06 | 1999-03-03 | 株式会社日本製鋼所 | ポリ乳酸共重合体の製造方法 |
US6369116B1 (en) * | 1995-06-02 | 2002-04-09 | Oculex Pharmaceuticals, Inc. | Composition and method for treating glaucoma |
JPH09227388A (ja) * | 1996-02-15 | 1997-09-02 | Naganushi Tetsuaki | 大腸癌、食道癌及び乳癌より選ばれた癌に用いる抗悪性腫瘍剤 |
AU2459497A (en) | 1996-05-31 | 1998-01-05 | Research And Development Institute, Inc. | Urinary medical devices |
US6229046B1 (en) | 1997-10-14 | 2001-05-08 | Cargill, Incorported | Lactic acid processing methods arrangements and products |
JP2000072680A (ja) * | 1998-08-25 | 2000-03-07 | Shiyumeidou:Kk | 免疫機能調節剤 |
JP2001139476A (ja) * | 1999-11-15 | 2001-05-22 | Youichirou Naganushi | 癌を含めた悪性新生物に用いる抗悪性腫瘍剤 |
RU2163810C1 (ru) * | 2000-05-18 | 2001-03-10 | Майорова Нина Федоровна | Состав для удаления доброкачественных новообразований на коже и слизистых и способ его получения |
CA2434573A1 (en) * | 2001-01-12 | 2002-07-18 | Amato Pharmaceutical Products, Ltd. | Agent for protection against microorganism infection |
WO2002060457A1 (fr) | 2001-01-24 | 2002-08-08 | Amato Pharmaceutical Products,Ltd. | Agents anti-stress |
US20020177624A1 (en) * | 2001-03-16 | 2002-11-28 | Calvin Hanna | Acetate-lactate buffering vaginal gel and for method of making same and treating bacterial vaginosis |
JP2002275256A (ja) * | 2001-03-19 | 2002-09-25 | Tendou Seiyaku Kk | 乳酸オリゴマーの製造方法 |
WO2003016259A2 (de) * | 2001-08-16 | 2003-02-27 | Pharmacon-Forschung Und Beratung Gmbh | Milchsäureelemente enthaltende verbindungen, deren herstellung sowie deren verwendung als pharmazeutische wirkstoffe |
CN1703230A (zh) | 2001-11-06 | 2005-11-30 | 天藤制药株式会社 | 含有乳酸寡聚物混合物的抗肿瘤剂 |
JP2004307561A (ja) | 2003-04-02 | 2004-11-04 | Tendou Seiyaku Kk | 環状乳酸オリゴマーの製造方法 |
DE602004002585T2 (de) | 2003-05-01 | 2007-10-25 | Innogene Kalbiotech Pte. Ltd. | Laktathaltige pharmazeutische Zusammensetzung und deren Verwendungen |
JP4316299B2 (ja) | 2003-06-03 | 2009-08-19 | 学校法人東海大学 | 鎖状乳酸オリゴマー誘導体およびその製造方法 |
JP2005126361A (ja) * | 2003-10-23 | 2005-05-19 | Tendou Seiyaku Kk | ポリ乳酸混合物を含むマトリックスメタロプロテアーゼ抑制剤 |
CN1562049A (zh) * | 2004-04-02 | 2005-01-12 | 聂四平 | 低聚果糖在制备治疗及预防***炎药中的应用 |
US20050271726A1 (en) * | 2004-06-02 | 2005-12-08 | Albert Crum | Immune enhancing compositions and methods of use thereof |
SE528337C2 (sv) | 2004-06-23 | 2006-10-24 | Nestor Medical Ab | Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet |
JP2006232909A (ja) | 2005-02-23 | 2006-09-07 | Tokai Univ | 環状オリゴ乳酸 |
JP4431102B2 (ja) | 2005-11-11 | 2010-03-10 | キャタピラージャパン株式会社 | カウンタウエイト及びカウンタウエイトの製造方法並びに作業機械 |
RU2308970C1 (ru) * | 2006-03-10 | 2007-10-27 | Автономная некоммерческая организация "Институт молекулярной диагностики" (АНО "ИнМоДи") | Антибактериальное средство для лечения внутриклеточных инфекций |
JP2007258526A (ja) | 2006-03-24 | 2007-10-04 | Konica Minolta Holdings Inc | 有機エレクトロルミネッセンス素子、及び有機エレクトロルミネッセンスディスプレイ |
JP2008157576A (ja) | 2006-12-26 | 2008-07-10 | Sharp Corp | 加湿機 |
WO2008119518A1 (en) | 2007-03-30 | 2008-10-09 | Laccure Ab | Use of oligomers of lactic acid in the treatment of gynaecological disorders |
-
2008
- 2008-03-28 WO PCT/EP2008/002505 patent/WO2008119518A1/en active Application Filing
- 2008-03-28 AU AU2008234064A patent/AU2008234064B2/en active Active
- 2008-03-28 DK DK08734874.4T patent/DK2142186T3/da active
- 2008-03-28 EP EP13183687.6A patent/EP2679222A1/en not_active Withdrawn
- 2008-03-28 CN CN201310450505.3A patent/CN103830216B/zh active Active
- 2008-03-28 JP JP2010500144A patent/JP5409596B2/ja active Active
- 2008-03-28 CN CN2008800161538A patent/CN101677980B/zh active Active
- 2008-03-28 CA CA2681803A patent/CA2681803C/en active Active
- 2008-03-28 MX MX2009010445A patent/MX2009010445A/es active IP Right Grant
- 2008-03-28 ES ES08734874.4T patent/ES2482190T3/es active Active
- 2008-03-28 KR KR1020097022696A patent/KR101518014B1/ko active IP Right Grant
- 2008-03-28 EP EP08734874.4A patent/EP2142186B1/en active Active
- 2008-03-28 RU RU2009140141/15A patent/RU2459620C2/ru active
- 2008-03-28 PT PT87348744T patent/PT2142186E/pt unknown
- 2008-03-28 BR BRPI0809330A patent/BRPI0809330B8/pt active IP Right Grant
- 2008-03-28 SI SI200831231T patent/SI2142186T1/sl unknown
- 2008-03-28 US US12/594,147 patent/US8425894B2/en active Active
- 2008-03-28 PL PL08734874T patent/PL2142186T3/pl unknown
-
2009
- 2009-10-15 ZA ZA2009/07215A patent/ZA200907215B/en unknown
-
2013
- 2013-03-28 US US13/852,668 patent/US8912232B2/en active Active
- 2013-08-01 JP JP2013160602A patent/JP5793542B2/ja not_active Expired - Fee Related
-
2014
- 2014-06-12 HR HRP20140559AT patent/HRP20140559T1/hr unknown
- 2014-06-20 US US14/311,200 patent/US9315444B2/en active Active
- 2014-06-26 CY CY20141100463T patent/CY1115310T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2142186E (pt) | Utilização de oligómeros de ácido láctico no tratamento de infeções ginecológicas | |
IL213070A0 (en) | Methods for the treatment of infections and tumors | |
EP2273989A4 (en) | POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS | |
ZA201005798B (en) | Treatment of microbial infections | |
HK1144553A1 (en) | Use of an acetylsalicylic acid salt for the treatment of viral infections | |
PL2276498T3 (pl) | Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii | |
IL207965A (en) | Compounds to treat or prevent pain | |
HK1143756A1 (en) | Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid n-phenylamides in the treatment of pain | |
GB0822486D0 (en) | Compounds for use in the treatment of pain | |
HRP20151393T8 (hr) | UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE | |
IL202506A0 (en) | Neramexane for the treatment of nystagmus | |
PL2117563T3 (pl) | Zastosowanie antybiotyków amidynoantracyklinowych do leczenia infekcji wirusowych | |
ZA201100468B (en) | The treatment of helminthic infections | |
IL212302A0 (en) | (pyrrolidin-2 -yl) phenyl derivatives for use in the treatment of pain | |
GB0821594D0 (en) | Improvements in or relating to the treatment of tissue damage | |
HK1139050A1 (en) | Medicament for the treatment of pneumonia | |
IL219444A (en) | Procine for use in the treatment of blood cell infections | |
GB2466110B (en) | Antibacterial formulation for use in the treatment of acne | |
GB0605035D0 (en) | Improvements In Or Relating To The Treatment Of Orthopaedic Infections | |
HK1198032A1 (en) | Nifuratel sulfoxide for use in the treatment of bacterial infections | |
GB0820562D0 (en) | Novel use and treatment | |
ZA200907826B (en) | Neramexane for the treatment of nystagmus | |
GB0700886D0 (en) | Medical treatment | |
GB0722338D0 (en) | Novel use and treatment | |
GB0801768D0 (en) | Treatment of microbial infections |